ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Amylyx Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Amylyx Pharmaceuticals INC. (Amylyx Pharmaceuticals Retirement Plan · EIN 46-4600503 · PN 001): $18.76M net assets, 121 active participants, and $7.18 per $10,000 (7.18 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAmylyx Pharmaceuticals INC.
Filing IdentifierAmylyx Pharmaceuticals Retirement Plan · EIN 46-4600503 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$18.76M
Active Participants121
Direct Admin Fee Rate$7.18 per $10,000 (7.18 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderADP Retirement Services
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI